This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML. The $3,149.12 firm fixed-price delivery order has a period of performance through December 3, 2024. The contract is not designated under any set-aside program, indicating open competition.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order appears to be part of that broader IDC agreement, facilitating the procurement of specialty medications and other critical medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/9/25, 1:01 AM